1291930

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

November 7, 2025

Fiscal Year

2026

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Dallas, TX (United States)

Additional Details